December 21 2021 FDA authorizes Pfizer-BioNTech coronavirus vaccine booster shots for 16- and 17-year-olds amid omicron threat FDA authorizes Pfizer-BioNTech coronavirus vaccine booster shots for 16- and 17-year-olds amid omicron threat – The Washington Post
News, Upcoming Events & News, Weekly Updates Pennsylvania Department of Health launches a new measles dashboard
News, Upcoming Events & News, Weekly Updates PAIC Submits Public Comment to ACIP Supporting Transparent, Evidence-Based Vaccine Policy
